Fecal proteases from diarrheic-IBS and ulcerative colitis patients exert opposite effect on visceral sensitivity in mice

[1]  V. Théodorou,et al.  M1185 High Fecal Serine-Protease Activity in IBD Patients Triggers Alterations of Paracellular Permeability in Mice Colon Through Par 4 Receptor Activation , 2008 .

[2]  A. Kawabata,et al.  Gastrointestinal roles for proteinase‐activated receptors in health and disease , 2008, British journal of pharmacology.

[3]  M. Steinhoff,et al.  Protease-activated receptors: novel PARtners in innate immunity. , 2007, Trends in immunology.

[4]  F. Nagy,et al.  A pilot study of fecal serine-protease activity: a pathophysiologic factor in diarrhea-predominant irritable bowel syndrome. , 2007, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[5]  N. Fukazawa,et al.  Cathepsin g is required for sustained inflammation and tissue injury after reperfusion of ischemic kidneys. , 2007, The American journal of pathology.

[6]  M. Steinhoff,et al.  Protease‐activated receptor‐4: a novel mechanism of inflammatory pain modulation , 2007, British journal of pharmacology.

[7]  Christine T. N. Pham,et al.  Neutrophil serine proteases: specific regulators of inflammation , 2006, Nature Reviews Immunology.

[8]  K. Sharkey,et al.  Visceral sensation and colitis: inflammation and hypersensitivity do not always go hand in hand , 2006, Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society.

[9]  M. Benson,et al.  Rectal afferent hypersensitivity and compliance in irritable bowel syndrome: differences between diarrhoea-predominant and constipation-predominant subgroups , 2006, European journal of gastroenterology & hepatology.

[10]  E. Lindström,et al.  Effect of DSS‐induced colitis on visceral sensitivity to colorectal distension in mice , 2006, Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society.

[11]  M. Hollenberg,et al.  Neutrophils and the kallikrein–kinin system in proteinase‐activated receptor 4‐mediated inflammation in rodents , 2005, British journal of pharmacology.

[12]  Emeran A. Mayer,et al.  Differences in brain responses to visceral pain between patients with irritable bowel syndrome and ulcerative colitis , 2005, Pain.

[13]  S. Vanner,et al.  Inflammation‐induced hyperexcitability of nociceptive gastrointestinal DRG neurones: the role of voltage‐gated ion channels , 2005, Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society.

[14]  F. Cerveró,et al.  Understanding the signaling and transmission of visceral nociceptive events. , 2004, Journal of neurobiology.

[15]  D. Santini,et al.  Activated mast cells in proximity to colonic nerves correlate with abdominal pain in irritable bowel syndrome. , 2004, Gastroenterology.

[16]  Jeom-Yong Kim,et al.  Role of mucosal mast cells in visceral hypersensitivity in a rat model of irritable bowel syndrome. , 2004, Journal of veterinary science.

[17]  R. Spiller,et al.  Relative importance of enterochromaffin cell hyperplasia, anxiety, and depression in postinfectious IBS. , 2003, Gastroenterology.

[18]  K. Kinnally,et al.  Neutrophil Cathepsin G Promotes Detachment-induced Cardiomyocyte Apoptosis via a Protease-activated Receptor-independent Mechanism* , 2003, Journal of Biological Chemistry.

[19]  K. Muramoto,et al.  Neutrophil Serine Proteinases Activate Human Nonepithelial Cells to Produce Inflammatory Cytokines Through Protease-Activated Receptor 21 , 2003, The Journal of Immunology.

[20]  M. Hollenberg,et al.  Proteinase-activated receptor-2 and human lung epithelial cells: disarming by neutrophil serine proteinases. , 2003, American journal of respiratory cell and molecular biology.

[21]  M. Hollenberg,et al.  Glycosylation of human proteinase-activated receptor-2 (hPAR2): role in cell surface expression and signalling. , 2002, The Biochemical journal.

[22]  Wangxue Chen,et al.  Activation of the mucosal immune system in irritable bowel syndrome. , 2002, Gastroenterology.

[23]  M. Hollenberg,et al.  International Union of Pharmacology. XXVIII. Proteinase-Activated Receptors , 2002, Pharmacological Reviews.

[24]  B. Guiard,et al.  Proteinases and proteinase-activated receptor 2: a possible role to promote visceral hyperalgesia in rats. , 2002, Gastroenterology.

[25]  D. Zochodne,et al.  Proteinase‐activated receptor‐1 agonists attenuate nociception in response to noxious stimuli , 2002, British journal of pharmacology.

[26]  P. Pasricha,et al.  Molecular cloning of the rat proteinase-activated receptor 4 (PAR4) , 2002, BMC Molecular Biology.

[27]  M. Hollenberg,et al.  Glycosylation and the activation of proteinase‐activated receptor 2 (PAR2) by human mast cell tryptase , 2001, British journal of pharmacology.

[28]  L. Chang,et al.  Perceptual responses in patients with inflammatory and functional bowel disease , 2000, Gut.

[29]  D. Fuchs,et al.  The role of psychological and biological factors in postinfective gut dysfunction , 2000, Gut.

[30]  Scott R. Presnell,et al.  Cloning and characterization of human protease-activated receptor 4. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[31]  C. Bernstein,et al.  Rectal afferent function in patients with inflammatory and functional intestinal disorders , 1996, PAIN®.

[32]  E A Mayer,et al.  Altered rectal perception is a biological marker of patients with irritable bowel syndrome. , 1995, Gastroenterology.

[33]  M. Delvaux,et al.  Evaluation of colonic sensory thresholds in IBS patients using a barostat , 1994, Digestive Diseases and Sciences.

[34]  Ami,et al.  Coated mesalazine (5-aminosalicylic acid) versus sulphasalazine in the treatment of active ulcerative colitis: a randomised trial. , 1989, BMJ.

[35]  H. Hodgson,et al.  Granulocyte migration in ulcerative colitis , 1985, European journal of clinical investigation.

[36]  J. Ritchie.  Pain from distension of the pelvic colon by inflating a balloon in the irritable colon syndrome 1 , 1973, Gut.

[37]  A. Papatsoris,et al.  DYSFUNCTION , 1952 .

[38]  N. Talley.  Increased faecal serine protease activity in diarrhoeic IBS patients: a colonic lumenal factor impairing colonic permeability and sensitivity , 2009 .